X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4387) 4387
ubiquitination (3862) 3862
life sciences & biomedicine (3698) 3698
humans (3346) 3346
animals (2310) 2310
ubiquitin (1825) 1825
proteins (1656) 1656
cell biology (1648) 1648
biochemistry & molecular biology (1446) 1446
mice (1249) 1249
ubiquitination - drug effects (1141) 1141
cell line, tumor (1044) 1044
signal transduction (948) 948
oncology (846) 846
ubiquitin-protein ligases - metabolism (843) 843
proteasome endopeptidase complex - metabolism (831) 831
cancer (829) 829
apoptosis (811) 811
phosphorylation (806) 806
proteolysis (717) 717
kinases (715) 715
gene expression (713) 713
science & technology - other topics (677) 677
multidisciplinary sciences (673) 673
hek293 cells (617) 617
cell line (614) 614
ubiquitin - metabolism (609) 609
research (595) 595
protein binding (570) 570
research article (563) 563
male (553) 553
mutation (548) 548
enzymes (519) 519
biology (517) 517
female (503) 503
cell cycle (501) 501
ubiquitin-protein ligase (473) 473
signal transduction - drug effects (447) 447
medicine (444) 444
science (439) 439
ubiquitin-protein ligases - genetics (438) 438
physiological aspects (436) 436
genetic aspects (420) 420
ligases (417) 417
degradation (387) 387
apoptosis - drug effects (384) 384
tumors (378) 378
cells, cultured (372) 372
cell proliferation (371) 371
analysis (369) 369
hela cells (369) 369
immunoprecipitation (350) 350
biochemistry (349) 349
health aspects (348) 348
dna damage (344) 344
genetics & heredity (332) 332
deoxyribonucleic acid--dna (311) 311
antineoplastic agents - pharmacology (310) 310
rna interference (309) 309
proteasomes (305) 305
rats (305) 305
proteolysis - drug effects (287) 287
autophagy (284) 284
transfection (275) 275
tumor suppressor protein p53 - metabolism (271) 271
ubiquitination - physiology (271) 271
mice, inbred c57bl (265) 265
proteasome (264) 264
protein stability (258) 258
protein processing, post-translational (253) 253
breast cancer (246) 246
phosphorylation - drug effects (244) 244
transcription (242) 242
ubiquitin-proteasome system (242) 242
rodents (240) 240
molecular biology (239) 239
dna repair (237) 237
amino acid sequence (234) 234
blotting, western (234) 234
neurosciences (234) 234
mice, knockout (231) 231
immunology (229) 229
transcription factors (228) 228
cell death (227) 227
nuclear proteins - metabolism (226) 226
ubiquitination - genetics (226) 226
cell proliferation - drug effects (223) 223
models, biological (214) 214
signaling (214) 214
gene expression regulation, neoplastic (209) 209
genes (208) 208
inflammation (203) 203
life sciences (203) 203
cell growth (202) 202
development and progression (202) 202
neurosciences & neurology (202) 202
physiology (201) 201
homeostasis (199) 199
medicine, research & experimental (199) 199
research & experimental medicine (199) 199
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5015) 5015
Japanese (17) 17
Chinese (8) 8
French (2) 2
Norwegian (2) 2
Portuguese (2) 2
Russian (2) 2
German (1) 1
Korean (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Proceedings of the National Academy of Sciences - PNAS, ISSN 1091-6490, 03/2008, Volume 105, Issue 12, pp. 4826 - 4831
To enhance therapeutic efficacy and reduce adverse effects, practitioners of traditional Chinese medicine (TCM... 
Up regulation | Acute promyelocytic leukemia | Arsenic | Medical treatment | Leukemia | Cell cycle | Cell lines | Mice | Cellular differentiation | Blood | Traditional Chinese medicine | Active ingredient | Systems biology | Synergism | Tetraarsenic tetrasulfide | Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Transcription, Genetic - drug effects | Oncogene Proteins, Fusion - metabolism | Leukemia, Promyelocytic, Acute - pathology | Humans | Drugs, Chinese Herbal - pharmacology | G1 Phase - drug effects | Aquaporins - genetics | Arsenicals - therapeutic use | Ubiquitination - drug effects | Protein Processing, Post-Translational - drug effects | Gene Expression Regulation, Neoplastic - drug effects | Drugs, Chinese Herbal - therapeutic use | Disease Models, Animal | Sulfides - pharmacology | Medicine, Chinese Traditional | Arsenicals - pharmacology | Aquaporins - metabolism | Sulfides - therapeutic use | Drug Synergism | Up-Regulation - drug effects | Animals | Cell Differentiation - drug effects | Cell Line, Tumor | Resting Phase, Cell Cycle - drug effects | Leukemia, Promyelocytic, Acute - genetics | Leukemia, Promyelocytic, Acute - drug therapy | Evaluation | Medicine, Chinese | Research | Drug synergism | Chinese medicine | Flowers & plants | Cells | Effectiveness studies | Index Medicus | systems biology | synergism | Biological Sciences | traditional chinese medicine | active ingredient | tetraarsenic tetrasulfide
Journal Article
Cell death & disease, ISSN 2041-4889, 03/2019, Volume 10, Issue 3, pp. 232 - 232
Journal Article
PloS one, ISSN 1932-6203, 08/2011, Volume 6, Issue 8, pp. e23888 - e23888
Cervical cancer cells exhibit an increased requirement for ubiquitin-dependent protein degradation associated with an elevated metabolic turnover rate, and for... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Heat-Shock Response - drug effects | Cyclin D1 - metabolism | Papillomaviridae - drug effects | Humans | Ubiquitin - metabolism | Uterine Cervical Neoplasms - pathology | Papillomaviridae - genetics | Chloroquine - pharmacology | Proteolysis - drug effects | Ubiquitination - drug effects | Biocatalysis - drug effects | Female | Antineoplastic Agents - pharmacology | Stress, Physiological - drug effects | Cell Death - drug effects | Polyubiquitin - metabolism | Cell Survival - drug effects | Tumor Stem Cell Assay | Tumor Suppressor Protein p53 - metabolism | Antineoplastic Agents - chemistry | Cell Adhesion - drug effects | Drug Synergism | Keratinocytes - drug effects | Protein Stability - drug effects | Cell Line, Tumor | HSP90 Heat-Shock Proteins - metabolism | Uterine Cervical Neoplasms - virology | Proteasome Endopeptidase Complex - metabolism | Proteasome Inhibitors | Drug Screening Assays, Antitumor | Ubiquitin | Care and treatment | Chemical inhibitors | Heat shock proteins | Prevention | Cell death | Proteolysis | Cancer cells | Tumor proteins | Papillomavirus infections | Cervical cancer | Cancer | Isoflavones | Flow cytometry | Hsp90 protein | Triterpenoids | Chloroquine | p53 Protein | Hydrocarbons | Oncology | Biochemistry | Stomach cancer | Turnover rate | Ovarian cancer | Anticancer properties | Degradation | Proteins | Antioxidants | Genotype & phenotype | Human papillomavirus | Antitumor agents | Pathways | Protein folding | Cooperation | Cell cycle | Polyphenols | Inhibition | Catalysis | Carbonyls | Bortezomib | Gynecology | Breast cancer | Cervix | Obstetrics | Tea | Signaling | Flavonoids | Active sites | Womens health | Pancreatic cancer | Proteasomes | Molecular biology | Apoptosis | Index Medicus
Journal Article
PloS one, ISSN 1932-6203, 08/2011, Volume 6, Issue 8, pp. e23756 - e23756
Background: Non-small cell lung cancer (NSCLC) patients with L858R or exon 19 deletion mutations in epidermal growth factor receptor (EGFR) have good responses... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Intestines - drug effects | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Adenocarcinoma - pathology | Apoptosis - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Intestines - metabolism | Antineoplastic Agents - administration & dosage | Curcumin - administration & dosage | Dose-Response Relationship, Drug | Receptor, Epidermal Growth Factor - metabolism | Adenocarcinoma - metabolism | Ubiquitination - drug effects | Quinazolines - administration & dosage | Antineoplastic Agents - pharmacology | p38 Mitogen-Activated Protein Kinases - metabolism | Phosphorylation - drug effects | Carcinoma, Non-Small-Cell Lung - pathology | Cell Line | Intestines - pathology | Carcinoma, Non-Small-Cell Lung - metabolism | Curcumin - pharmacology | Enzyme Activation - drug effects | Mice, SCID | Adenocarcinoma - drug therapy | Blotting, Western | Drug Synergism | Xenograft Model Antitumor Assays | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cell Line, Tumor | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Cell Proliferation - drug effects | Mice | Carcinoma, Non-Small-Cell Lung - drug therapy | Quinazolines - pharmacology | Drug Resistance, Neoplasm - drug effects | Ubiquitin | Tyrosine | Epidermal growth factor | Analysis | Lung cancer, Non-small cell | Gefitinib | Mitogens | Protein kinases | Adenocarcinoma | Cell proliferation | Therapy | Biotechnology | Animal models | Phosphorylation | Mucosa | Xenotransplantation | Lung cancer | Kinases | Cyclin D1 | Anticancer properties | Degradation | c-Met protein | Cell activation | Ubiquitination | Antitumor agents | Clonal deletion | Intestine | Rodents | Xenografts | Curcumin | Inhibition | Protein-tyrosine kinase | Epidermal growth factor receptors | Poly(ADP-ribose) polymerase | Non-small cell lung carcinoma | MAP kinase | Patients | Inflammatory bowel disease | Antitumor activity | In vivo methods and tests | Combined treatment | Mutation | Apoptosis | Index Medicus | Activation
Journal Article